✦ LIBER ✦

Regenerative therapy of infrabony defects with or without systemic doxycycline. A randomized placebo-controlled trial

✍ Scribed by Lasse Röllke; Beate Schacher; Martin Wohlfeil; Ti-Sun Kim; Jens Kaltschmitt; Jörg Krieger; Diana M. Krigar; Peter Reitmeir; Peter Eickholz

Book ID: 109361357
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 203 KB
Volume: 39
Category: Article
ISSN: 0303-6979
DOI: 10.1111/j.1600-051x.2012.01861.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized, placebo-controlled, crossove

Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis

✍ P. Woo; T. R. Southwood; A.-M. Prieur; C. J. Doré; J. Grainger; J. David; C. Ryd 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 2 views

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder

✍ Lesley M. Arnold; Amy Rosen; Yili Lu Pritchett; Deborah N. D'Souza; David J. Gol 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 265 KB

Interim Analysis of a Randomized Placebo

Interim Analysis of a Randomized Placebo-Controlled Pilot Trial of Armodafinil for Fatigue in Patients with Malignant Gliomas Undergoing Radiotherapy with or without Standard Chemotherapy

✍ S.E. Weiss; J. Drappatz; A. Muzikansky; A. Norden; S. Ruland; A. Ciampa; L. Dohe 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

A randomized, 48-week, placebo-controlle

A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: A pilot study

✍ Kathleen M Hoeger; Lynda Kochman; Nellie Wixom; Kimberly Craig; Richard K Miller 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 205 KB

Randomized Phase III Placebo-Controlled

Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

✍ Wolff, A. C.; Lazar, A. A.; Bondarenko, I.; Garin, A. M.; Brincat, S.; Chow, L.; 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 194 KB

Randomized, double-blind, placebo-contro

Randomized, double-blind, placebo-controlled trial of the once-daily GLP-1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea (GetGoal-L-Asia)

✍ Y. Seino; K. W. Min; E. Niemoeller; A. Takami; on behalf of the EFC10887 GETGOAL 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 602 KB